Atlas Trials

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Clinical trial NCT00952237 · COMPLETED

Trial details

NCT number
NCT00952237
Sponsor
Dartmouth-Hitchcock Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple MyelomaOther Plasma Cell Dyscrasia (Waldenstrom, Amyloidosis)Leukemia
Start date
2003-01-01
Primary completion
2011-04-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.